Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2017-06-29 Regulatory Filings
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Sonoma Pharmaceuticals, Inc. It relates to the registration of securities under the Securities Act of 1933, specifically for stock incentive plans. The document includes details about the securities to be registered, calculation of registration fees, incorporation by reference of other filings, indemnification provisions, and exhibits. Form S-8 is a registration statement used for employee benefit plans and stock incentive plans, which is a type of capital raising or securities registration filing. This is not an annual report, earnings release, or any other financial report type. It is a regulatory filing related to securities registration and employee stock plans. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a proxy statement but a full registration statement filing.
2017-06-29 English
FORM 10-K
Annual Report FY 2017
2017-06-28 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 5, 2017, by Sonoma Pharmaceuticals, Inc. It announces the issuance of a press release containing financial results for the fiscal quarter and year ended March 31, 2017. The text explicitly states that the press release is furnished as an exhibit and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act. The document itself does not contain detailed financial statements or substantive financial data but rather serves as a current report announcing the financial results release. This matches the characteristics of an Earnings Release (ER) filing, which is the initial announcement of quarterly or periodical financial results with key highlights only. The document length is 4194 characters, which is consistent with a brief announcement rather than a full report. Therefore, the appropriate classification is Earnings Release (ER).
2017-06-05 English
OWNERSHIP DOCUMENT
Director's Dealing
2017-06-01 English
OWNERSHIP DOCUMENT
Director's Dealing
2017-06-01 English
OWNERSHIP DOCUMENT
Director's Dealing
2017-06-01 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.